RESEARCH DOSSIER
Psychotherapy for Personality Pathology and Self-Harm
Abstract. This fundamental research monograph examines psychotherapy for enduring personality pathology and recurrent self-harm, integrating the historical development of structured treatments, their theoretical mechanisms, randomized comparative trials, adolescent evidence, prospective longitudinal outcomes, professional guidelines, and major evidence syntheses. Its central research questions concern the outcomes of dialectical behavior therapy, mentalization-based treatment, schema therapy, transference-focused psychotherapy, and structured general psychiatric management; the relation between treating personality dysfunction and preventing repeated injury; and the interpretation of comparative efficacy, safety, engagement, and long-term functioning. The methodology is a critical narrative synthesis of identifiable original trials, longitudinal studies, systematic reviews, and clinical recommendations, with explicit attention to design, comparator quality, treatment fidelity, attrition, outcome definitions, and generalizability. Evidence supports the value of structured psychotherapy and selected interventions for recurrent self-harm in defined clinical populations. Confidence in a universal hierarchy among specialist modalities remains limited, and measured behavioral improvement should be differentiated from diagnostic remission, functional recovery, and rare lethal outcomes. Future research requires stronger head-to-head comparisons, transparent adverse-event monitoring, individualized treatment matching, meaningful long-term endpoints, and accountable evaluation of artificial and digital clinical support.
Keywords: borderline personality disorder; personality pathology; psychotherapy; dialectical behavior therapy; mentalization-based treatment; schema therapy; transference-focused psychotherapy; general psychiatric management; nonsuicidal self-injury; suicide attempts; adolescent self-harm; therapeutic mechanisms; clinical trials; comparative effectiveness; patient safety; long-term recovery; longitudinal studies; clinical guidelines; Artificial Era
Scientific Overview and Research Questions
Psychotherapy for personality pathology and self-harm concerns the modification of persistent difficulties in self-organization, interpersonal functioning, affect regulation, and behavioral control when those difficulties coexist with recurrent deliberate injury, suicidal crises, or threats to continuity of care. The clinical literature most often studies borderline personality disorder (BPD), because its diagnostic history and trial infrastructure created an identifiable research population. Yet personality pathology also includes maladaptive traits and impairments that cross diagnostic thresholds. Self-harm occurs in many diagnostic and social contexts, so an intervention's evidence for BPD cannot automatically be generalized to every patient who harms themselves.
The research questions are specific. Which structured psychotherapies improve personality symptoms, functioning, or the frequency of self-injury? What outcome differences appear when an intervention is compared with routine care, an enhanced structured comparator, or another specialist psychotherapy? Which findings extend beyond a treatment year and across adolescence or adulthood? How do study design, event definitions, treatment dose, and attrition influence conclusions? How should clinical systems integrate evidence about psychotherapy with ongoing safety assessment without confusing prevention of injury with remission of a personality diagnosis?
The object of analysis is psychotherapy outcomes and their clinical conditions. Diagnostic classification, the general etiology of personality disorders, acute emergency management, and the distinct historical development of individual treatments are treated insofar as they explain outcomes. The neighboring Science monographs on Counseling Psychology and Psychotherapy and Clinical Psychology and Psychopathology supply the disciplinary background. This dossier synthesizes trials, longitudinal observational research, clinical guidelines, and evidence reviews. It is a critical narrative monograph; no original participant data, preregistered systematic search, meta-analysis, or clinical trial is claimed.
Concepts and Outcome Domains
Personality functioning refers to relatively enduring patterns of identity, self-direction, empathy, intimacy, and interpersonal adaptation. Personality pathology describes marked difficulties in such functioning together with maladaptive traits or recurrent patterns of distress and impairment. Borderline personality disorder remains a widely studied clinical syndrome involving instability in relationships, self-experience, mood regulation, and impulsive behavior, sometimes accompanied by suicidal or nonsuicidal self-injury. These phenomena overlap clinically while retaining different definitions, developmental trajectories, and treatment endpoints.
The term self-harm requires an explicit operational definition. The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) encompasses intentional self-poisoning or injury irrespective of apparent purpose. Many North American studies distinguish nonsuicidal self-injury, suicide attempts, suicidal ideation, and composite self-harm. A suicide attempt involves some intent to die, whereas an episode classified as nonsuicidal self-injury does not. Intent can be uncertain or fluctuate within and across events. Reviewers must therefore preserve each trial's original categories rather than equating an incident count, an episode requiring medical care, and a suicide death.
The outcome hierarchy has several layers. Behavioral outcomes include recurrence, frequency, severity, medical consequences, emergency visits, hospitalization, and suicide attempts. Syndromal outcomes include symptom severity and diagnostic remission. Patient-centered outcomes include occupational participation, educational continuity, relationships, self-defined recovery, and quality of life. Process outcomes include engagement, retention, alliance, coping skills, and reductions in destructive interpersonal cycles. The Zanarini (2012) shows why sustained symptomatic remission and broader functional recovery must be measured separately. Their trajectories are related but not interchangeable.
Historical Emergence of the Treatment Problem
Modern psychotherapy research inherited a historical problem: clinicians observed repeated crises and interpersonal distress among patients whose needs were poorly served by short, symptom-focused contacts. Earlier psychodynamic traditions emphasized conflicts in identity, defenses, relational expectations, and treatment relationships. Behavioral and cognitive traditions emphasized learning contingencies, dysregulated responses, behavioral rehearsal, and modification of interpretable patterns. Later integrative approaches organized these observations into manualized treatment programs with explicit targets, supervision, and assessable outcomes.
The introduction of randomized studies transformed the field from clinical case formulations into comparative intervention science. In Linehan (1991), women meeting BPD criteria and showing chronic parasuicidal behavior received dialectical behavior therapy or community treatment as usual. The yearlong trial reported advantages for DBT on self-injurious events, medical severity, psychotherapy retention, and inpatient days at several assessment points, while differences were absent for several other symptom scales. The historically used term parasuicide in this publication should be read within the study's original definitions; current research uses more differentiated terminology.
Research subsequently broadened beyond treatment versus loosely defined usual care. Specialist comparisons appeared, including Clarkin (2007), McMain (2009), and Bateman (2009). These studies made the organization of the comparison treatment itself a scientific variable. A structured, coherent, adequately supervised service can improve outcomes; specialist branded treatments must be evaluated against that stronger standard.
Later evidence syntheses examined entire programs and the certainty of their effects. The Storebø (2020) included 75 trials and 4,507 participants and emphasized low-certainty results for many individual modality effects. Historical importance, clinical plausibility, and evidence certainty therefore occupy separate dimensions of scientific evaluation.
Research Design and Evidence Appraisal
Randomized controlled trials estimate outcomes under a particular allocation and comparator. Their internal validity depends on allocation procedures, missing data, assessor blinding where possible, treatment fidelity, and the handling of repeated events. Behavioral events may have a skewed distribution, with some patients reporting multiple recurrences while others have none. Choosing whether to analyze the proportion of people with any repeat episode, event rates, time to first event, or event severity changes the inferential target. Predefined intention-to-treat analyses and transparent accounts of dropout are crucial in a population where treatment discontinuation can itself be clinically consequential.
Studies of psychotherapy cannot generally blind patients or therapists to the intervention. Expectancy, allegiance, therapist expertise, supervision, and access to between-session support may differ between arms. The comparison named treatment as usual is especially heterogeneous: it might range from intermittent contacts to a coordinated specialist service. An advantage over loosely organized care supports the tested package under those conditions. Evidence of a treatment-specific mechanism requires more direct component, mediation, or experimental identification.
Qualitative and longitudinal designs provide complementary knowledge. Interviews can describe the lived meaning of repeated crises and the practical barriers to treatment; cohort follow-up clarifies recovery over years. Yet symptom remission observed in a cohort cannot be assigned causally to one psychotherapy without appropriate comparison. The Gunderson (2011) illustrates the value of repeated observation of symptoms and functioning; it is not a randomized comparison of psychotherapy brands.
In the present synthesis, an individual study is described at the level supported by its accessible abstract or full record. Numerical claims are restricted to source-verified values. Systematic reviews are treated as secondary evaluations, not as original participants or independent replications of all trials they include. Guideline statements are identified as professional recommendations whose strength, date, jurisdiction, and underlying research base remain visible.
Personality Organization and Interpersonal Vulnerability
Persistent personality pathology involves difficulties stabilizing a coherent self-representation across changing emotional and relational contexts. Rapid threat appraisals, abandonment concerns, distrust, shame, emotional lability, anger, and impulsive response patterns can produce recurring sequences of interpersonal strain followed by intense distress. These processes vary considerably across individuals; they are clinical formulations rather than an invariant causal model for everyone with a personality disorder.
A treatment formulation needs to identify how vulnerabilities become events. For one patient, an interpersonal rupture may precede overwhelming arousal, constricted attention, and injurious behavior. For another, dissociation, substance use, obsessive rumination, trauma reminders, or prolonged hopelessness may be more prominent. The sequence must be investigated through collaborative inquiry into actual episodes, longitudinal history, and current protective resources. Apparent correlations between an emotion and an event can reflect reciprocal causation or shared stressors.
Psychotherapy programs differ in their proximal targets. DBT trains skills for distress tolerance, emotional regulation, interpersonal effectiveness, and mindful awareness while organizing a hierarchy of immediate behavioral targets. MBT emphasizes the restoration of the capacity to understand one's own and others' mental states amid attachment-related arousal. Schema therapy addresses entrenched meaning structures, emotional needs, modes, and learned coping patterns. Transference-focused psychotherapy examines integration of split or polarized representations of self and others as they emerge in the therapeutic relationship. Good psychiatric management emphasizes a coherent formulation, practical functioning, collaborative treatment, and coordinated professional responsibility.
These accounts generate distinct mechanistic predictions, but evidence that two packages work does not prove their proposed mechanisms. Causal change may also involve non-specific components such as reliable contact, explicit collaborative goals, more predictable responses to crises, and a durable therapeutic relationship. Mechanism tests must measure proposed intermediate change before the target outcome and account for feedback between evolving symptoms and the therapist's actions.
Self-Harm as a Dynamic Clinical Process
An episode of self-harm is a time-bound event with antecedents, internal experiences, social context, behavioral consequences, and subsequent interpretations. Within-person functional analysis may reveal rapidly changing motives such as relief from intolerable arousal, interruption of dissociation, communication of distress, self-directed anger, or attempts to influence an unbearable interpersonal situation. The motives of one episode should never be presumed to explain all future episodes.
Clinical safety depends on the distinction between recent acts and projected future risk. A patient with no recent injury can still require careful assessment of suicidal ideation, planning, access to lethal means, changing circumstances, and support. Conversely, an individual with chronic nonsuicidal self-injury requires individualized assessment rather than automatic placement in a rigid risk group. National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) advises against using risk scales or low/medium/high global categories to determine future suicide or repeat self-harm and emphasizes a collaboratively developed formulation of needs and immediate and longer-term safety.
Behavioral change is rarely linear. A person may progress in recognizing warning signs and seeking support while still experiencing episodes during major stress. Counting only complete abstinence can conceal reductions in frequency, severity, or the need for acute services, while a favorable symptom score can conceal a serious recurrence. Trials should report these domains individually and respect the distribution and timing of events.
The treatment relationship should remain stable enough to discuss incidents candidly, to assess shifts in suicidal intent, and to revise plans after crises. A punitive response may impair disclosure and continuity. Safety-oriented treatment includes assessment, accessible coordination with clinicians and relevant supports, appropriate response to acute danger, and monitoring that is proportionate to the person's circumstances.
Diagnostic Classification and Dimensional Formulation
Traditional categorical BPD trials usually recruited patients using contemporaneous diagnostic interviews based on DSM criteria. Those inclusion criteria facilitated comparability but often excluded persons with major substance use, acute psychosis, severe cognitive impairment, or other conditions that remain common in practice. Findings therefore describe selected trial populations. The movement toward dimensional models of personality disorder makes severity of personality functioning and maladaptive traits important as additional research variables.
The coexistence of depressive disorders, posttraumatic symptoms, eating pathology, substance-related disorders, and neurodevelopmental differences can influence both injury patterns and care access. Diagnostic labels alone do not determine how a person responds to treatment. A clinically useful assessment specifies the severity and type of functional impairment, recurrent injury patterns, current intent, treatment goals, capacity to participate in the planned intervention, and social determinants that affect access.
This approach also improves the interpretation of outcome studies. When a trial selects patients with recurrent suicidality as well as BPD, its findings may be informative about a specific high-risk subgroup without establishing the same magnitude of benefit for all personality presentations. When another trial measures global functioning rather than self-harm, its primary endpoint addresses a different scientific claim. The analyst must maintain a mapping from sample definition to intervention, comparator, endpoint, follow-up interval, and certainty of inference.
Ethical Foundations and Patient-Centered Recovery
Psychotherapy for personality pathology operates within unusually consequential decisions about autonomy, confidentiality, involuntary intervention, coordinated crisis care, and potential injury. Ethical competence includes respect for the person's account of distress and goals, ongoing informed consent, transparent discussion of the evidence, realistic communication about the scope and duration of treatment, and clear explanation of how acute safety concerns will be managed.
A personality diagnosis must not become a reason to deny treatment or to assume that an individual is resistant to help. The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) explicitly cautions against withholding appropriate psychological interventions because of diagnosis, age, coexisting conditions, or substance misuse. The Keepers (2024) recommends structured psychotherapy supported by research and a person-centered treatment plan, reflecting the clinical importance of coordinated, explainable care.
Patient-centered recovery extends beyond fewer emergency presentations. Meaningful progress can include improved relationships, employment or study, a stable sense of agency, reduced shame, safer ways to communicate distress, and an ability to reconstruct life after earlier trauma. These outcomes require direct measurement rather than inference from diagnostic remission. Long-term psychological recovery is evaluated across time, relationships, and contexts, not merely at the end of a scheduled treatment package.
Dialectical Behavior Therapy and Behavioral Targeting
Dialectical behavior therapy emerged through Marsha Linehan's program of behavioral treatment for recurrent life-threatening behavior among patients diagnosed with BPD. Its clinical logic connects acceptance strategies with structured behavioral change. A comprehensive program commonly integrates individual therapy, skills training, between-session generalization support, and team consultation. The target hierarchy prioritizes behaviors that threaten life, then behaviors that undermine therapy, followed by patterns that interfere with quality of life and the acquisition of behavioral capabilities. This ordering is fundamental to the treatment's empirical identity: a study of an isolated skills course cannot be assumed to evaluate the entire DBT package.
The foundational Linehan (1991) provided early evidence of reduced recurrent self-injurious behavior and improved retention relative to treatment as usual in the population studied. The follow-up Linehan (2006) improved comparator credibility by contrasting DBT with community therapy by experts. Its 101 participants were clinically referred women with recent suicidal and self-injurious behavior meeting DSM-IV BPD criteria. Across one treatment year and one follow-up year, the trial found advantages for DBT on several suicidal-behavior and service-use endpoints. The finding supports efficacy in a specific high-risk adult sample, with acknowledged limits for other populations and implementation settings.
DBT combines several theoretical claims: contingencies shape behavior; emotional vulnerability interacts with an invalidating environment; cognitive and attentional skills can expand alternative responses; and therapist consultation supports treatment stability. Evidence for a complete program does not establish the independent causal contribution of every component. Research on adaptation, skills acquisition, treatment fidelity, and component comparisons therefore matters for both the mechanism and the practicality of implementation.
The Storebø (2020) found evidence favoring DBT over treatment as usual for several BPD-relevant outcomes, while grading the evidence for these modality-specific effects as low certainty. The scientific conclusion is differentiated: DBT is an established, research-supported psychotherapy, particularly relevant to recurrent self-harm, while precise comparative superiority and the size of durable benefits remain active research questions.
Mentalization-Based Treatment and Social Understanding
Mentalization-based treatment was developed around the hypothesis that severe interpersonal stress can impair the capacity to understand behavior in terms of beliefs, feelings, intentions, and other mental states. In this formulation, crises may involve rapid shifts from nuanced interpretation to certainty, threat attribution, or behavioral urgency. MBT seeks to restore reflective capacity through a structured clinical stance, attention to mental states in current interactions, and exploration of disruptions in understanding that develop in treatment.
Its theoretical appeal is closely connected to attachment research and the interpersonal organization of emotion. It does not require assuming that every self-harm event is caused by a mentalization failure. A testable formulation specifies circumstances under which reflective capacity changes, which emotional and interpersonal outcomes follow, and how these changes relate temporally to later injury. Changes in attachment expectations and reflective activity may be relevant process measures, but they should be studied without treating theoretical vocabulary as direct evidence.
The Bateman (2009) contrasted MBT with structured clinical management among people with BPD. The comparison is important because both groups received organized professional care. Findings favoring MBT on several measured outcomes must be interpreted in relation to the particular participants, treatment delivery, and endpoints rather than extrapolated to every setting or diagnosis.
A later adolescent study, Rossouw (2012), tested a version of MBT in a population of young people with self-harm. Its importance lies in extending the theoretical question toward developmental transitions while raising the need for independent, multisite replication and clarification of how family context, age, and treatment engagement alter outcomes. The Cochrane review reports potentially beneficial MBT effects on self-harm and suicidality compared with usual treatment but emphasizes low certainty. Thus MBT is a significant treatment framework with a growing empirical record and an ongoing need for robust comparative and mechanistic testing.
Schema Therapy and Entrenched Emotional Patterns
Schema therapy conceptualizes enduring clinical difficulties through recurring maladaptive beliefs, emotional needs, coping responses, and rapidly shifting schema modes. Its treatment methods include cognitive work, behavioral change, experiential techniques, relational consistency, and careful attention to the therapeutic relationship. It offers a formulation of how early interpersonal learning may become reactivated during current conflicts and affectively charged experiences.
The Giesen-Bloo (2006) compared schema-focused therapy with transference-focused psychotherapy for patients with BPD in an outpatient setting. The comparison helped establish that structured psychological approaches other than DBT were plausible treatment options and that clinically meaningful outcomes could be examined across years of treatment. It also exemplifies the difficulty of separating treatment theory from treatment dose, therapist training, supervision, and patient preferences in a comparison between elaborate specialist packages.
Schema therapy trials commonly evaluate personality symptoms, quality of life, and social functioning. Those findings cannot be presented as direct estimates of prevention of suicide attempts unless that outcome was defined and measured appropriately. The model's relation to self-injury may operate through shame, self-criticism, emotional distress, and coping responses, yet mechanistic statements require prospective intermediate measurements.
Scientific interpretation should also distinguish standard schema therapy from variants with group components, shortened duration, or adaptations for different disorders. Brand continuity does not guarantee intervention equivalence. Future comparisons should report treatment intensity, contact hours, competence, and which specific therapeutic operations were delivered, because these properties influence both outcomes and real-world feasibility.
Transference-Focused Psychotherapy and Identity Integration
Transference-focused psychotherapy draws on object-relations theory and aims to promote greater integration of representations of self and others. It focuses particularly on polarized interpersonal interpretations, shifting relationship expectations, and intense affective responses as they become observable within the therapeutic relationship. These processes can be studied through changes in personality organization, reflective functioning, aggression, and interpersonal functioning.
In Clarkin (2007), 90 patients diagnosed with BPD were randomized to transference-focused psychotherapy, DBT, or a dynamic supportive treatment, with blind ratings at repeated intervals over one year. All three groups improved on several broad indicators including depression, anxiety, and functioning. Variation in the pattern of improvement across particular domains illustrates how a treatment might influence some aspects of pathology more than others without establishing one universally dominant modality.
The Giesen-Bloo (2006) supplies a second direct specialist comparison. Differences reported in this trial must be placed alongside the broader field's small number of head-to-head studies and potential influences of service context, treatment implementation, and selected populations. A scientifically credible account recognizes TFP as an extensively theorized and empirically investigated psychotherapy while keeping certainty about comparative effects proportional to the available randomized evidence.
For self-harm-specific conclusions, the decisive evidence is not theoretical expectation alone but the measurement of recurrent events, intention, medical consequences, and follow-up. Many trials give personality symptom scales a central role and therefore cannot supply equally precise answers about rare outcomes such as suicide deaths.
General Psychiatric Management and Structured Clinical Care
General psychiatric management (GPM) organizes treatment around a coherent explanation of BPD, interpersonal hypersensitivity, shared practical goals, functional recovery, coordinated care, and available psychiatric and social supports. Its research significance extends beyond its clinical manual: it creates a credible and replicable comparator for high-intensity specialist psychotherapy. This matters when routine services already incorporate regular engagement, crisis planning, supportive psychotherapy, and appropriate management of comorbidity.
The McMain (2009) assigned 180 patients with BPD and a history of repeated suicidal or nonsuicidal self-injury to DBT or GPM. Both arms were coherent clinical programs. The study found substantial clinical improvement in both conditions and did not establish consistent DBT superiority across the main outcomes under examination. The finding is frequently misread when presented as evidence that specialized psychological treatment adds no value. It instead shows that treatment quality in the comparison group is essential to the estimated difference between therapies.
Structured clinical management is also relevant to MBT trials. Such comparators involve explicit plans, professional consistency, and attention to recurrent crises, all of which can influence meaningful outcomes. In health-services research, there is therefore no single universal treatment-as-usual condition. An adequately staffed specialist community team and inconsistent fragmented contact are different interventions, even when both are described in manuscripts as usual care.
Effective implementation depends on matching care complexity and intensity to individual need. A named therapy may be clinically appropriate for a person who wants its methods and can participate in the program. A structured, person-centered generalist framework can also be a meaningful evidence-based option, particularly where specialist training, geographic access, or resources are limited. Comparative research must investigate both efficacy and service feasibility without making resources an excuse for denying necessary care.
Comparison of Specialist Psychotherapies
A scientifically useful comparison begins with endpoints and active ingredients rather than an informal ranking of brands. DBT places explicit emphasis on life-threatening behavior and skill generalization. MBT addresses reflective functioning under interpersonal stress. Schema therapy focuses on maladaptive meaning structures and coping modes. TFP emphasizes integration of representations in the treatment relationship. GPM offers a coherent pragmatic clinical framework. Each program includes relational engagement, an explanatory model, structured sessions, and a response to crisis.
The Storebø (2020) reported no compelling subgroup evidence of differing treatment effects between psychotherapy types in comparisons against usual care, while noting low-certainty estimates for numerous modality-specific analyses. The later Keepers (2024) recommends a structured approach to psychotherapy that has support in the literature and targets core BPD features. The guideline's formulation emphasizes evidence-supported structure without making a single program mandatory for every patient.
Differences in dose, duration, and provider expertise complicate head-to-head inference. One trial may compare a comprehensive yearlong multimodal program with a weekly individual psychotherapy, while another gives both arms team supervision and crisis access. A larger symptom reduction could reflect modality-specific mechanisms, greater exposure to competent care, or differential retention. The purpose of comparative psychotherapy science is to discriminate these explanations rather than merely count favorable trials.
Treatment matching remains a central challenge. Patients vary in dissociation, emotion dysregulation, interpersonal patterns, substance-related problems, traumatic experiences, motivation, age, language, and available social support. Future trials need prespecified, clinically meaningful moderators and interactions, sufficiently large samples, and replication. Post hoc claims that one therapy is best for a particular subgroup are exploratory until independently confirmed.
Psychotherapy Components, Dose, and Fidelity
The concept of a treatment package encompasses more than a list of techniques. It includes session frequency, expected treatment duration, staff preparation, supervision, accessibility during crises, referral coordination, and rules for managing missed appointments and treatment-interfering behavior. Each dimension may affect the relation between treatment assignment and observed improvement. Clinical researchers need a reproducible intervention description to know what was tested.
Fidelity instruments assess adherence to a treatment model and competence in delivery. They can reveal whether a null trial result reflects a weak theoretical mechanism, inadequate implementation, or underpowered estimation. However, high fidelity measured after treatment assignment may itself be related to patient response, therapist expertise, and organizational resources. Statistical associations between fidelity and outcome should not automatically be described as proof of a specific therapeutic causal ingredient.
Treatment duration must also be evaluated in relation to its target. A brief intervention after self-harm may aim to improve safety and access to follow-up, whereas a course for enduring personality difficulties may seek longer-term change in behavior, self-image, and functioning. The National Institute for Health and Care Excellence. (2009). Borderline personality disorder: Recognition and management (Clinical guideline CG78). (2009) recommends that psychological care be structured and supervised and advises against using interventions lasting less than three months as stand-alone BPD-specific treatment outside an appropriate service framework. This guidance has a different target from short self-harm interventions and should not be conflated with them.
Researchers should document treatment exposure and dropout, analyze randomized groups according to prespecified principles, and distinguish participant preference from treatment efficacy. Service systems should evaluate whether the program can be delivered safely and consistently without widening inequalities of access.
Mechanisms and Causal Attribution
Theoretical explanations of psychotherapy change require three distinguishable claims. The first is that the treatment is associated with improvement. The second is that a proposed intermediate variable changes during treatment and predicts later outcomes. The third is that manipulating that variable would change outcomes under relevant clinical conditions. Randomized treatment allocation strongly informs the first claim, but it usually does not directly establish the third.
DBT studies sometimes measure skills use, emotion regulation, or reductions in experiential avoidance. MBT studies may assess reflective functioning and interpretive flexibility. Schema and psychodynamic studies may evaluate maladaptive beliefs, interpersonal representations, and relational functioning. Each construct requires an instrument appropriate to the population and a time scale capable of detecting change before injury-related outcomes. Repeated assessments can help distinguish early process changes from consequences of already improving symptoms.
Several mechanisms could interact. Improved communication with clinicians might increase early disclosure of ideation and make crisis intervention timely; greater coping capacity might reduce the need for self-injury after stress; reduced shame may increase attendance; and a more reliable clinical relationship may alter expectations of rejection. These hypotheses are compatible with several treatment traditions. Claims about a unique mechanism need experimental component tests, plausible causal models, temporal measurement, and independent replication.
Mechanism research should not displace the question of adverse effects. An intervention that reduces self-reported emotional intensity but increases concealment or dropout could appear favorable on one scale while worsening the capacity to detect crises. Patient-centered research must monitor what interventions do, how they work, and what unintended consequences occur.
Recurrent Self-Harm Outcomes in Adults
The scientific literature on self-harm includes people with several mental-health conditions and patients who do not meet criteria for a personality disorder. Its results should be synthesized separately from BPD-only trials. A treatment can reduce repetition after an emergency presentation without changing a long-standing personality pattern; a long-term BPD program can improve interpersonal functioning without sufficiently precise statistical power to show a change in rare suicide deaths. Treatment setting, index episode, and eligibility criteria determine what a result means.
The Witt (2021b) included 76 trials involving 21,414 adults. The authors found indications that individual CBT-based approaches may reduce repeated self-harm over later follow-up, while immediate post-intervention effects were uncertain and many intervention comparisons were supported by limited evidence. They described possible frequency reductions with DBT and called for further evaluation of other psychosocial programs. Pooling across all those clinical settings does not provide a direct estimate for the subgroup of people with BPD.
The review's methodological implications are substantial. Repeat-event definitions, exposure to other treatments, incomplete follow-up, and differences in control care influence the estimate of recurrence. Suicide deaths are statistically rare, making single trials generally underpowered to evaluate mortality. A reduction in self-injury or in medically treated episodes should be reported as precisely that outcome. It is encouraging and clinically relevant while remaining distinct from an established survival benefit.
For patients who present with repeated episodes, treatment research supports an approach that connects immediate assessment and continuity with a longer formulation of psychological and social needs. The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) include a structured, person-centered CBT-informed intervention for adults who self-harm, typically four to ten sessions, alongside an individualized care plan. This recommendation addresses a specific self-harm pathway and does not imply that four sessions constitute comprehensive psychotherapy for enduring BPD.
Adolescent Self-Harm and Developmental Adaptation
Adolescence entails rapid changes in emotion regulation, autonomy, family relationships, peer status, and service transitions. Repeated self-harm during these years can reflect different developmental and clinical pathways; many adolescents who self-harm do not have BPD, and the validity of a treatment finding does not depend on assigning that diagnosis. Trials need to describe age, gender composition, family involvement, prior attempts, and the availability of suitable follow-up.
Mehlum (2014) randomized 77 adolescents with recent repetitive self-harm to an adapted DBT program or enhanced usual care in outpatient services. The trial supported DBT-A on relevant outcomes during the treatment period. Its strength is a directly measured behavior in a developmentally defined population; its limitation is that a relatively modest sample cannot establish universality across cultural settings or quantify rare lethal outcomes.
In a larger multisite U.S. investigation, McCauley (2018) evaluated DBT against individual and group supportive therapy among 173 high-risk adolescents aged 12 to 18 years. The trial reported favorable immediate treatment-end outcomes for DBT on suicidal and self-harm behaviors. The use of an active supportive comparison and multiple sites increases the relevance of the evidence. Researchers must still distinguish treatment-end results, subsequent follow-up, and differential participation.
The Witt (2021a) judged several findings uncertain and highlighted the need to evaluate adolescent DBT further. This synthesis supports targeted development of effective treatment while warning against generalizing single-site estimates to all children or treating every family or group intervention as equivalent. The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) suggests considering DBT adapted for adolescents with significant emotion dysregulation and frequent self-harm, with attention to age and transitions between services.
Mentalization Approaches in Young People
Adolescent MBT examines whether improving the capacity to interpret thoughts and feelings under relational stress can modify repeated self-harm. The Rossouw (2012) compared mentalization-based treatment for adolescents with usual care and reported promising results. The theoretical proposition is clear: mentalizing processes should change before and help explain later reductions in self-harm. Evidence for that mediation is more demanding than evidence that outcomes differ between randomized arms.
Subsequent synthesis limits the certainty of universal claims. The Witt (2021a) found very-low-certainty evidence regarding repetition under MBT-A compared with usual care, with sparse and heterogeneous trials. An apparently positive individual trial can coexist with a pooled conclusion of substantial uncertainty because precision, methodological constraints, and variation across settings change the strength of inference.
Treatment decisions in adolescent services also require family-sensitive assessment, school coordination, safeguarding, and careful transitions into adult care. Where family participation is therapeutically useful, privacy, autonomy, and trust need explicit negotiation. No single mechanistic model accounts for the broad heterogeneity of self-harm during development.
Brief Intervention, Safety Planning, and Continuity
The immediate period after a self-harm episode is an opportunity for collaborative safety assessment and engagement. Brief clinical interventions can provide a bridge between urgent care and continuing psychotherapy. They have a distinct intervention target from long-term treatment of personality pathology and should be evaluated on their own terms.
Stanley (2012) formalized the Safety Planning Intervention as a collaborative approach to warning signs, coping strategies, supportive contacts, professional resources, and environmental safety. In the Stanley (2018), emergency-department safety planning combined with structured follow-up was associated with reduced subsequent suicidal behavior and improved engagement in outpatient care relative to usual care. The study's cohort-comparison design, population, and combined intervention limit claims of an isolated randomized effect of a written safety plan.
National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) recommends collaborative safety planning and emphasizes ongoing psychosocial assessment, continuity, and access to appropriate follow-up. Risk tools should not be used as gatekeeping instruments for treatment or discharge, and predictive risk categories should not replace formulation of needs. Clinical pathways ought to be evaluated for actual follow-through: a referral that is recorded but inaccessible is a different intervention from an appointment that the patient can attend.
Safety planning may be incorporated into DBT, MBT, GPM, and other treatments while preserving their distinct psychotherapeutic work. The research question is whether a program succeeds in maintaining contact during periods when distress, risk, and motivation change. Service evaluation should include delayed follow-up, missed appointments, and barriers to reengagement.
Comparative Evidence and Confidence in Findings
Evidence synthesis must distinguish the number of studies from their independent information content. Many trials recruit from specialist centers with strong allegiance to the model being tested. A meta-analysis may include multiple studies from related research teams and a substantial number of trials with small samples. Between-program conclusions are especially uncertain when most comparisons rely on separate control groups and only a few direct head-to-head randomized studies exist.
The Storebø (2020) identified 75 BPD psychotherapy trials with 4,507 participants. Benefits of BPD-tailored psychotherapy relative to usual treatment were reported for several outcomes, but the authors emphasized imprecision and low-certainty evidence for specific interventions. The review found insufficient evidence to establish a robust hierarchy among modalities. Its caution applies even where an individual prominent trial reported a clinically meaningful benefit.
An independent Crotty (2024) synthesized 25 psychotherapy studies with 2,545 participants under its inclusion criteria. It likewise did not identify strong evidence that one psychotherapy is consistently superior to another, while finding evidence for structured psychotherapy over usual care with varying certainty across modalities. The two reviews have different eligibility criteria and therefore different totals; their sample counts should not be summed as if they represented disjoint populations.
A related scientific issue is what counts as clinically important. A statistically significant difference on a symptom scale may fall below a predefined threshold for meaningful patient improvement. Conversely, a change in severe but infrequent self-injury may be clinically important despite uncertain statistical precision. A responsible synthesis reports direction, magnitude when verified, certainty, comparator, and the patient's relevant goals without compressing them into a single claim of effectiveness.
Longitudinal Recovery and Functional Life
Longitudinal clinical cohorts changed the once-prevalent expectation that BPD symptoms necessarily remain fixed. The Gunderson (2011) and the Zanarini (2012) documented substantial possibilities for symptomatic improvement over time. These findings matter for prognosis and recovery expectations, but cohort improvement can result from several interacting influences, including psychotherapy, social change, maturation, and selection effects.
Functional recovery may lag behind remission of diagnostic symptoms. Educational disruption, employment difficulties, impoverished relationships, medical illness, and recurrent social disadvantage can persist after episodes become less frequent. A long-term treatment program should therefore be evaluated on more than the count of crises during its scheduled sessions. Recovery-oriented measurement connects symptom assessment to employment or education, stable housing, social relationships, and self-defined quality of life.
Relapse and recurrence research should define the interval during which a person is considered improved and how worsening is detected. Treatment extension and booster care may be helpful in some circumstances, yet evidence about optimal duration and maintenance models remains incomplete. Patients and services need access to reentry pathways rather than a rule that every episode of renewed distress invalidates earlier gains.
Treatment Engagement and Discontinuation
The capacity of patients to enter, remain in, and return to care is a measurable treatment outcome. Dropout can reflect adverse treatment experience, logistical obstacles, mismatch with patient preferences, symptom severity, geographic inequity, stigma, or improvement sufficient to make further sessions unnecessary. These explanations have different meanings. Research treating all discontinuation as identical risks misrepresenting both treatment acceptability and effectiveness.
The Linehan (2006) reported differential treatment retention favoring DBT in its clinical sample. Retention is particularly important when ongoing professional access helps identify and respond to changing suicide-related concerns. Nevertheless, retention alone is an indirect indicator of success; a participant can remain in an intervention without achieving meaningful improvement, and a patient may successfully transfer to a preferable service.
Engagement is shaped by treatment burden. Intensive multi-component programs may offer close support but require substantial travel time, scheduling flexibility, costs, and availability of trained clinicians. Social inequalities can limit who receives the full intervention tested in trials. Future studies should treat accessibility as a primary implementation outcome and report how incomplete treatment exposure affects the comparison.
Adverse Outcomes and Safety of Psychotherapy
Clinical trials in this area must record injury events, hospitalization, worsening of suicidal ideation, loss to follow-up, and other adverse outcomes. The absence of a recorded adverse event does not establish that no harm occurred. The Storebø (2020) identified limited adverse-event reporting across the included psychotherapy trials. This weakens certainty about comparative safety even when benefits on symptoms or self-harm outcomes are observed.
Psychotherapy can involve distress during exposure to difficult memories, strong emotions in the treatment relationship, or temporary increases in perceived vulnerability. Such responses require clinical interpretation and appropriate monitoring. They are not equivalent to injury or treatment failure, but should also not be dismissed without assessing severity, duration, and functional consequences. Service quality, professional competence, boundary maintenance, and availability of crisis support affect safety.
The clinical stance should be collaborative and transparent. Patients must be able to communicate worsening symptoms, question treatment fit, and participate in revisions. When clinical conditions require a change in intensity of care, a handoff should protect continuity and explain responsibilities. Where danger is immediate, appropriate professional emergency assessment and intervention remain part of responsible care. This monograph presents research and guideline analysis, not an individualized treatment protocol.
Individualized Treatment Planning Across Levels of Need
A treatment plan for personality pathology with recurrent self-harm must specify distinct domains of need: current safety, enduring difficulties in personality functioning, psychiatric comorbidity, access to supportive relationships, and the person's preferred goals. These domains form a changing clinical configuration. A period of acute suicidal concern may require urgent assessment and intensified contact, while a comparatively stable interval can support focused work on enduring interpersonal patterns and life participation.
The Keepers (2024) emphasizes comprehensive assessment, a documented person-centered treatment plan, collaborative discussion of diagnosis, and structured psychotherapy supported by research. It also recommends reviewing current and earlier treatments, comorbid conditions, and medications. The guideline's psychotherapeutic emphasis is important because improvement depends on sustained care and because treatment selection should incorporate patient preference and the feasibility of completing an intervention.
The choice among DBT, MBT, schema therapy, TFP, GPM, and other structured approaches can be organized as a transparent process. Clinicians identify the immediate behavioral risks and goals, determine what treatment packages are locally available at adequate fidelity, discuss their burden and expected duration, and monitor outcomes that matter to the individual. Such decision making requires clinical expertise; a psychotherapy trial supplies a probability distribution for a research population rather than a deterministic treatment prescription for one person.
Adaptive treatment research can compare predefined stepped-care sequences, changes in intensity following nonresponse, and patient-informed selection. This is more informative than retrospective explanations of why a clinician selected a favored method. An adaptive design should specify the intervention transition, the outcome that triggers it, and the independent consequences of changing care.
Comorbidity, Trauma, and Competing Clinical Demands
Personality pathology commonly coexists with depression, posttraumatic symptoms, substance-related problems, eating disorders, anxiety, and physical illness. These conditions can alter both the presentation of self-harm and the tolerability of specific psychotherapeutic methods. Comorbidity is sometimes excluded from research samples or inadequately described, leaving clinically important uncertainty about generalization to real services.
Treatment planning should consider whether an acute co-occurring condition requires its own focused intervention, whether conditions can be addressed within the selected personality-focused psychotherapy, and whether several simultaneous therapies create an unsustainable burden. Evidence for one diagnosis cannot simply be transferred to another. The existence of overlapping symptoms may support an integrated formulation while maintaining distinct evidence claims for each clinical endpoint.
Traumatic experience is relevant in many cases, yet the relation between trauma and current injury patterns varies. A personal history of adversity informs collaborative assessment and therapeutic pacing; it does not license an assumed universal mechanism. Treatment research needs to distinguish symptom improvement, distress during trauma-focused work, completion of the intervention, and long-term safety. Patients should be able to discuss preferences and adverse experiences without presuming that initial difficulty means the planned care should automatically be abandoned.
Substance use, dissociation, and acute interpersonal crises can complicate behavioral monitoring. The clinical method therefore needs flexible communication among qualified providers, with clear responsibility for treatment decisions and explicit consent when information is shared. Such coordination should be evaluated as part of the intervention rather than described as an incidental administrative detail.
Culture, Identity, Language, and Inequalities of Access
Most landmark BPD psychotherapy trials took place in specialist mental-health settings and recruited samples that reflected local diagnostic, referral, and health-care systems. International transportability depends on how social expectations, language, family structure, stigma, insurance arrangements, and access to specialist therapists shape engagement. A psychological process observed in one setting may have wider relevance, while the exact treatment package and event-detection methods remain context dependent.
Research should document ethnicity, socioeconomic circumstances, gender identity, age, disability, immigration context, and location where ethically and scientifically relevant. Such data make subgroup comparisons possible, but small sample sizes and overlapping social determinants make simplistic categorical conclusions unreliable. The appropriate question concerns the interaction between structural conditions, treatment access, implementation, and outcomes.
Self-harm may be stigmatized in clinical, educational, or family systems. People can avoid disclosure when they expect blame, restrictive reactions, or loss of agency. Clinician training should include collaborative interpretation, trauma-informed communication, and knowledge of the service conditions under which patients can safely seek help. The National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) explicitly include discussion of stigma and advise psychosocial assessment focused on the individual rather than deterministic risk classifications.
Digital delivery can reduce some access barriers while introducing others, including privacy, internet reliability, private space for sessions, and capacity to respond to acute danger. The ethical and scientific assessment of accessibility therefore extends to how a treatment is actually delivered and whether its safety infrastructure remains operational.
Implementation, Cost, and Workforce Organization
Evidence-based psychotherapy requires a service organization capable of delivering the intervention that clinical trials describe. Comprehensive DBT can involve individual sessions, group skills training, between-session support, and consultation teams. MBT, schema therapy, TFP, and GPM involve different requirements for supervision, professional preparation, contact schedules, and clinical coordination. The availability of a treatment name on a service directory is not equivalent to consistent delivery of that model.
Workforce shortages, clinician turnover, and fragmented referral systems can disrupt the continuity that long-term psychotherapy needs. Such factors modify the effective treatment dose and the likelihood that a patient remains engaged. Implementation studies should record staff training, competence, caseload, turnover, fidelity, cost, and whether people referred after emergency presentations actually receive continuing care. Clinical effects observed in highly supported research settings may shrink or change when these conditions are absent.
A strong implementation comparison tests treatment packages as they are realistically available. It can examine specialist programs versus enhanced coordinated general care, stepped interventions, or hybrid pathways that preserve a core set of clinical principles. Cost-effectiveness requires accounting for staff time, supervision, emergency care, hospitalization, and the person's ability to resume ordinary activity. Costs are associated with different outcomes at different time horizons, and a short observation window can miss downstream consequences.
The McMain (2009) demonstrates why structured comparators matter: a good general psychiatric management program may itself achieve meaningful improvement. Health services should learn from this insight by investing in consistent, accessible care as well as in specialist expertise.
Clinical Measurement and Outcome Interpretation
A clinically useful research instrument must be matched to its target construct. Diagnostic interviews can establish trial eligibility and evaluate remission; self-report symptom scales capture experienced distress; behavior interviews or event diaries estimate self-harm; records may verify emergency presentations and hospitalization; interviews and social-function scales clarify recovery. Combining these sources is valuable because each has different sources of error and missingness.
For repeated self-harm, event frequency and the proportion of people with recurrence are related but different estimands. A person with ten events and a person with one event contribute equally to a binary recurrence indicator. A severe event may also be clinically consequential despite no change in average event frequency. Trials should state whether they measured nonsuicidal self-injury, suicide attempts, self-poisoning, emergency-treated events, injury severity, or a composite, and whether measurements depended on recall or independently assessed records.
Statistical comparisons should be interpreted on the study's own time scale. Treatment-end differences may attenuate or change after discharge; durable improvement requires follow-up of sufficient duration and adequate handling of patients whose outcomes are unknown. The Zanarini (2012) highlights the distinctiveness of sustained symptomatic remission and broader recovery. Investigators should avoid claiming complete recovery when the only measured endpoint was a symptom score or cessation of a narrowly defined behavior.
Patient-reported outcomes can capture a recovery dimension that institutional records overlook. The evaluation should ask whether an individual feels able to plan a future, maintain relationships, pursue study or work, and seek help without coercive expectations. Such goals are heterogeneous but measurable when specified before assessment.
Causal Inference, Replication, and Reporting Bias
Random assignment to treatment reduces baseline confounding between intervention groups but does not identify every downstream mechanism. If one program contains greater session intensity, more coordinated crisis response, and a distinct technique, an observed group difference belongs to the composite intervention until additional comparisons isolate its components. Attrition, incomplete outcome reporting, differential therapist expertise, and expectancy complicate the interpretation further.
Small trials are particularly susceptible to imprecision and unstable subgroup estimates. A study can show a statistically significant effect on one outcome among many tests even when its broad pattern is uncertain. Meta-analytic combination can improve precision but must evaluate shared samples, selective reporting, risk of bias, heterogeneity, and study-level dependence. The Storebø (2020) and Crotty (2024) illustrate the central need to separate evidence of structured treatment benefit from confidence in superiority among named psychotherapies.
Preregistration of primary outcomes, transparent protocols, complete event definitions, intention-to-treat analyses, and accessible descriptions of fidelity improve cumulative knowledge. Independent multisite replication is especially valuable when a treatment was developed and first studied by researchers with strong theoretical investment in its success. Registration and disclosure standards should include adverse events and reasons for withdrawal.
Future studies should use clinically meaningful endpoints, patient-centered outcome sets, and sufficient follow-up. They should also investigate whether changes in intermediate variables temporally precede changes in self-harm instead of relying solely on cross-sectional associations. These measures would make it possible to compare interventions on both effectiveness and plausible causal explanation.
Digital Services, Artificial Systems, and Clinical Accountability
Artificially mediated technologies may assist with appointment reminders, symptom journaling, psychoeducational resources, and structured self-monitoring. Their role in personality-related distress and recurrent self-harm requires particularly careful evaluation because crises involve shifting intent, incomplete disclosure, relational context, and the need for accountable human intervention. A system that can generate helpful text has not thereby demonstrated equivalence to an independently evaluated psychotherapy package.
The scientific questions are operational. Can a digital intervention reliably identify when a patient needs human clinical attention? Does it increase engagement with validated treatment, or displace necessary professional contact? How does it affect privacy, disclosure, adherence, and adverse-event detection? What evidence supports its use among patients with recent self-harm rather than in general wellness populations? Without direct outcome studies, benefits remain hypotheses.
In the Artificial Era, interactions between Homo and Artificial introduce new forms of psychological mediation and potential continuity of support. The clinical unit of analysis remains the documented intervention, its human governance, and its observable outcomes. Licensed professionals and services retain responsibility for emergency pathways, clinical judgment, informed consent, record protection, and correction of system failures.
Artificial systems can have a research role in analyzing patterns of care, linking event timelines, and auditing access if adequate privacy and validation requirements are met. Predictive performance does not automatically confer clinical utility. Any algorithm used in self-harm care must be assessed for false positives, false negatives, transportability, calibration, and consequences of its recommendations. National Institute for Health and Care Excellence. (2022). Self-harm: Assessment (2022) cautions against using aggregate risk scales to determine management or predict future suicide; computational tools do not exempt health services from these limitations.
Unresolved Questions and Research Priorities
Several empirical questions remain open. First, comparative effectiveness among adequately implemented structured psychotherapies is uncertain for many endpoints and patient groups. Larger and more diverse head-to-head trials could test treatment matching without presuming in advance that a single brand should dominate. Second, the contribution of intervention components requires designs that isolate skill practice, relational strategies, crisis coordination, and treatment intensity while preserving clinical safety.
Third, developmentally appropriate pathways need stronger evidence across adolescents, emerging adults, and older patients. Fourth, follow-up studies should measure both repeated injury and improvements in work, education, relationships, and quality of life. Fifth, research should examine how treatment preferences, trust, and service accessibility influence engagement and outcome. Sixth, adverse-event monitoring and transparent reporting should become routine rather than an optional feature.
Seventh, the validity of mechanistic claims depends on reliable repeated measures and appropriately timed causal tests. Eighth, health systems need pragmatic studies of what interventions they can deliver consistently with sustainable staffing. Ninth, digital and artificial components require independent safety and outcome assessment in the specific risk population. Tenth, cross-national research can clarify which findings reflect transportable treatment processes and which depend on local service structures or culturally specific conditions.
These questions are scientifically connected. Better causal inference requires better measurement; reliable measurement requires access and trust; meaningful long-term outcomes require continuity beyond the research clinic; and treatment implementation determines whether trial efficacy becomes everyday benefit.
Conclusion
Psychotherapy for personality pathology and self-harm is an established field of clinical intervention research that has moved from early manualized programs to comparisons among several coherent treatment systems. Randomized trials support the potential of structured psychotherapies to improve clinically important outcomes, including recurrent self-harm in appropriately selected populations. The cumulative evidence supports treatment engagement, continuity, and meaningful patient-centered goals while retaining uncertainty about which specific psychotherapy is superior for which patient and on which endpoint.
The strongest scientific account distinguishes the treatment of enduring personality dysfunction from immediate safety-oriented care and from the prevention of recurrent injury. DBT, MBT, schema therapy, TFP, and GPM contribute distinct theoretical models and empirically studied clinical structures. Their differences deserve comparative investigation; their common requirements for trained clinicians, predictable care, collaborative formulation, and evidence-based monitoring deserve equal analytical attention.
Clinical safety and long-term recovery are interconnected but separately measured. The research agenda therefore combines careful behavioral event definitions, sustained functional outcomes, clinical adverse-event reporting, direct specialist comparisons, investigation of mechanisms, attention to diversity and access, and valid tests of digital support. Across these domains, high-quality psychotherapy research advances when its claims remain tied to identifiable studies, precise outcome definitions, transparent uncertainty, and actual conditions of care.
References
- Bateman, A., & Fonagy, P. (2009). Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry, 166(12), 1355–1364. https://doi.org/10.1176/appi.ajp.2009.09040539
- Clarkin, J. F., Levy, K. N., Lenzenweger, M. F., & Kernberg, O. F. (2007). Evaluating three treatments for borderline personality disorder: A multiwave study. American Journal of Psychiatry, 164(6), 922–928. https://doi.org/10.1176/ajp.2007.164.6.922
- Crotty, K., Viswanathan, M., Kennedy, S., Edlund, M. J., Ali, R., Siddiqui, M., Wines, R., Ratajczak, P., & Gartlehner, G. (2024). Psychotherapies for the treatment of borderline personality disorder: A systematic review. Journal of Consulting and Clinical Psychology, 92(5), 275–295. https://doi.org/10.1037/ccp0000833
- Giesen-Bloo, J., van Dyck, R., Spinhoven, P., van Tilburg, W., Dirksen, C., van Asselt, T., Kremers, I., Nadort, M., & Arntz, A. (2006). Outpatient psychotherapy for borderline personality disorder: Randomized trial of schema-focused therapy vs transference-focused psychotherapy. Archives of General Psychiatry, 63(6), 649–658. https://doi.org/10.1001/archpsyc.63.6.649
- Gunderson, J. G., Stout, R. L., McGlashan, T. H., Shea, M. T., Morey, L. C., Grilo, C. M., Zanarini, M. C., Yen, S., Markowitz, J. C., Sanislow, C., Ansell, E., Pinto, A., & Skodol, A. E. (2011). Ten-year course of borderline personality disorder: Psychopathology and function from the Collaborative Longitudinal Personality Disorders Study. Archives of General Psychiatry, 68(8), 827–837. https://doi.org/10.1001/archgenpsychiatry.2011.37
- Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M., Choi-Kain, L., Nelson, K. J., Oldham, J. M., Sharp, C., Degenhardt, A., Fochtmann, L. J., Oldham, J. M., Hong, S. H., & Medicus, J. (2024). The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 181(11), 1024–1028. https://doi.org/10.1176/appi.ajp.24181010
- Linehan, M. M., Armstrong, H. E., Suarez, A., Allmon, D., & Heard, H. L. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48(12), 1060–1064. https://doi.org/10.1001/archpsyc.1991.01810360024003
- Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63(7), 757–766. https://doi.org/10.1001/archpsyc.63.7.757
- McCauley, E., Berk, M. S., Asarnow, J. R., Adrian, M., Cohen, J., Korslund, K., Avina, C., Hughes, J., Harned, M., Gallop, R., & Linehan, M. M. (2018). Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: A randomized clinical trial. JAMA Psychiatry, 75(8), 777–785. https://doi.org/10.1001/jamapsychiatry.2018.1109
- McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner, D. L. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166(12), 1365–1374. https://doi.org/10.1176/appi.ajp.2009.09010039
- Mehlum, L., Tørmoen, A. J., Ramberg, M., Haga, E., Diep, L. M., Laberg, S., Larsson, B. S., Stanley, B. H., Miller, A. L., Sund, A. M., & Grøholt, B. (2014). Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: A randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 53(10), 1082–1091. https://doi.org/10.1016/j.jaac.2014.07.003
- National Institute for Health and Care Excellence. (2009). Borderline personality disorder: Recognition and management (Clinical guideline CG78). https://www.nice.org.uk/guidance/cg78/chapter/Recommendations
- National Institute for Health and Care Excellence. (2022). Self-harm: Assessment, management and preventing recurrence (NICE guideline NG225). https://www.nice.org.uk/guidance/ng225/chapter/recommendations
- Rossouw, T. I., & Fonagy, P. (2012). Mentalization-based treatment for self-harm in adolescents: A randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 51(12), 1304–1313.e3. https://doi.org/10.1016/j.jaac.2012.09.018
- Stanley, B., & Brown, G. K. (2012). Safety planning intervention: A brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice, 19(2), 256–264. https://doi.org/10.1016/j.cbpra.2011.01.001
- Stanley, B., Brown, G. K., Brenner, L. A., Galfalvy, H. C., Currier, G. W., Knox, K. L., Chaudhury, S. R., Bush, A. L., & Green, K. L. (2018). Comparison of the Safety Planning Intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry, 75(9), 894–900. https://doi.org/10.1001/jamapsychiatry.2018.1776
- Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T., Mattivi, J. T., Jørgensen, M. S., Faltinsen, E., Todorovac, A., Sales, C. P., Callesen, H. E., Lieb, K., & Simonsen, E. (2020). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 2020(5), CD012955. https://doi.org/10.1002/14651858.CD012955.pub2
- Witt, K. G., Hetrick, S. E., Rajaram, G., Hazell, P., Taylor Salisbury, T. L., Townsend, E., & Hawton, K. (2021a). Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews, 2021(3), CD013667. https://doi.org/10.1002/14651858.CD013667.pub2
- Witt, K. G., Hetrick, S. E., Rajaram, G., Hazell, P., Taylor Salisbury, T. L., Townsend, E., & Hawton, K. (2021b). Psychosocial interventions for self-harm in adults. Cochrane Database of Systematic Reviews, 2021(4), CD013668. https://doi.org/10.1002/14651858.CD013668.pub2
- Zanarini, M. C., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2012). Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: A 16-year prospective follow-up study. American Journal of Psychiatry, 169(5), 476–483. https://doi.org/10.1176/appi.ajp.2011.11101550